Suppressor of Cytokine Signaling-1 Regulates the Sensitivity of Pancreatic β Cells to Tumor Necrosis Factor
Open Access
- 1 August 2002
- journal article
- Published by Elsevier
- Vol. 277 (31) , 27945-27952
- https://doi.org/10.1074/jbc.m110214200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Suppressor of Cytokine Signaling-1 Attenuates the Duration of Interferon γ Signal Transduction in Vitro and in VivoPublished by Elsevier ,2001
- SOCS-1 can suppress CD3ζ- and Syk-mediated NF-AT activation in a non-lymphoid cell lineFEBS Letters, 2000
- Prolonged STAT1 Activation Is Associated with Interferon-γ Priming for Interleukin-1-induced Inducible Nitric-oxide Synthase Expression by Islets of LangerhansJournal of Biological Chemistry, 1999
- SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this CytokineCell, 1999
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- Modulation of life and death by the TNF receptor superfamilyOncogene, 1998
- Interleukin-1β-induced Rat Pancreatic Islet Nitric Oxide Synthesis Requires Both the p38 and Extracellular Signal-regulated Kinase 1/2 Mitogen-activated Protein KinasesJournal of Biological Chemistry, 1998
- Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.The Journal of Experimental Medicine, 1995
- Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.Journal of Clinical Investigation, 1994
- In situ islet cytokine gene expression during development of type I diabetes in the non-obese diabetic mouseImmunology Letters, 1994